Alliancebernstein L.P. Reata Pharmaceuticals Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$79.22 - $105.37 $4.93 Million - $6.56 Million	62,262 Added 90.27%	131,235 $13.4 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $1.37 Million - $4.13 Million	-44,366 Reduced 39.14%	68,973 $6.27 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $1.74 Million - $3.3 Million	78,439 Added 224.75%	113,339 $4.31 Million
Q2 2022 Aug 15, 2022	BUY	$20.71 - $36.5 $16,568 - $29,200	800 Added 2.35%	34,900 $1.06 Million
Q1 2022 May 13, 2022	BUY	$24.12 - $39.6 $2,412 - $3,960	100 Added 0.29%	34,100 $1.12 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $5,122 - $22,192	-200 Reduced 0.58%	34,000 $897,000
Q2 2021 Jul 30, 2021	BUY	$78.27 - $151.29 $1.95 Million - $3.77 Million	24,931 Added 268.97%	34,200 $4.84 Million
Q1 2021 May 06, 2021	SELL	$94.25 - $132.81 $252,684 - $356,063	-2,681 Reduced 22.44%	9,269 $924,000
Q4 2020 Feb 08, 2021	SELL	$102.03 - $184.62 $10,203 - $18,462	-100 Reduced 0.83%	11,950 $1.48 Million
Q3 2020 Nov 12, 2020	BUY	$93.53 - $163.34 $60,794 - $106,171	650 Added 5.7%	12,050 $1.17 Million
Q2 2020 Aug 13, 2020	SELL	$126.3 - $176.56 $4.4 Million - $6.15 Million	-34,830 Reduced 75.34%	11,400 $1.78 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $49,664 - $99,096	400 Added 0.87%	46,230 $6.67 Million
Q4 2019 Feb 18, 2020	BUY	$74.57 - $217.92 $1.49 Million - $4.36 Million	20,030 Added 77.64%	45,830 $9.37 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $38,860 - $47,175	-500 Reduced 1.9%	25,800 $2.43 Million
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $145,320 - $285,012	2,800 Added 11.91%	26,300 $2.25 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $76.44 $4,876 - $7,644	-100 Reduced 0.42%	23,500 $1.32 Million
Q3 2018 Nov 08, 2018	BUY	$35.64 - $92.06 $203,148 - $524,742	5,700 Added 31.84%	23,600 $1.93 Million
Q2 2018 Aug 13, 2018	BUY	$19.94 - $40.96 $35,892 - $73,728	1,800 Added 11.18%	17,900 $626,000
Q1 2018 May 14, 2018	BUY	$20.0 - $30.19 $38,000 - $57,361	1,900 Added 13.38%	16,100 $330,000
Q3 2017 Nov 13, 2017	BUY	$26.29 - $31.88 $373,318 - $452,696	14,200	14,200 $442,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account